Skip to content
Adam Torkildson – Lifestyle
Author:
OKYO Pharma LTD
OKYO Pharma Announces Purchase of Shares by Director
July 23, 2026
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
July 23, 2026
OKYO Pharma Announces Purchase of Shares by Chairman
July 22, 2026
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director
July 22, 2026
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
July 22, 2026
OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
July 21, 2026
OKYO Pharma Announces Purchase of Shares by Chairman
July 21, 2026
OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans
July 20, 2026
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
July 8, 2026
OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium
July 7, 2026
1
2
Next Page
→